A first-of-its-kind antiviral gel may offer the potential to stop papillomavirus (HPV) infection before it causes cancer. ( ...

From 2008 to 2022, rates for precancerous lesions decreased about 80 percent among 20- to 24-year-old women who were screened ...

A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the ...

Cervical cancer deaths have dropped due to better screening, but fewer women are keeping up with tests. An AXA Health ...

The study shows an almost 80% drop in rates of cervical precancers among women ages 20-24 from 2008 to 2022, correlating to vaccine uptake. Simultaneously, an mRNA pancreatic cancer vaccine is showing ...

A study looking at the impact of the human papillomavirus or HPV vaccine showed that in the period from 2008 to 2022, the ...

Genital HPV infections are thought to be responsible for more than 99% of cervical cancers. At least partly because the ...

The vaccine reduces your chances of getting human papillomavirus (HPV), a common virus that's spread through skin contact ...

Why it matters: The CDC report shows that rates of precancerous lesions among women aged 20-24 screened for cervical cancer ...

The human papillomavirus (HPV) vaccine is having a huge impact on cervical cancer prevention among young women, a U.S.